282 related articles for article (PubMed ID: 8230497)
1. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.
Barcelo P; Wuhl O; Servitge E; Rousaud A; Pak CY
J Urol; 1993 Dec; 150(6):1761-4. PubMed ID: 8230497
[TBL] [Abstract][Full Text] [Related]
2. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate.
Pak CY; Fuller C
Ann Intern Med; 1986 Jan; 104(1):33-7. PubMed ID: 3940503
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment of calcium nephrolithiasis with potassium citrate.
Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
[TBL] [Abstract][Full Text] [Related]
5. Can citrate therapy prevent nephrolithiasis?
Abdulhadi MH; Hall PM; Streem SB
Urology; 1993 Mar; 41(3):221-4. PubMed ID: 8442301
[TBL] [Abstract][Full Text] [Related]
6. Citrate salts for preventing and treating calcium containing kidney stones in adults.
Phillips R; Hanchanale VS; Myatt A; Somani B; Nabi G; Biyani CS
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010057. PubMed ID: 26439475
[TBL] [Abstract][Full Text] [Related]
7. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
[TBL] [Abstract][Full Text] [Related]
8. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.
Preminger GM; Sakhaee K; Skurla C; Pak CY
J Urol; 1985 Jul; 134(1):20-3. PubMed ID: 4009822
[TBL] [Abstract][Full Text] [Related]
9. Effect of orange juice consumption on urinary stone risk factors.
Wabner CL; Pak CY
J Urol; 1993 Jun; 149(6):1405-8. PubMed ID: 8501777
[TBL] [Abstract][Full Text] [Related]
10. Citrate and renal calculi: an update.
Pak CY
Miner Electrolyte Metab; 1994; 20(6):371-7. PubMed ID: 7783699
[TBL] [Abstract][Full Text] [Related]
11. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
[TBL] [Abstract][Full Text] [Related]
12. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
13. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis.
Pak CY; Peterson R; Sakhaee K; Fuller C; Preminger G; Reisch J
Am J Med; 1985 Sep; 79(3):284-8. PubMed ID: 4036979
[TBL] [Abstract][Full Text] [Related]
14. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
[TBL] [Abstract][Full Text] [Related]
15. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.
Ettinger B; Pak CY; Citron JT; Thomas C; Adams-Huet B; Vangessel A
J Urol; 1997 Dec; 158(6):2069-73. PubMed ID: 9366314
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of "specific" potassium citrate therapy versus conservative management in nephrolithiasis of mild to moderate severity.
Preminger GM; Harvey JA; Pak CY
J Urol; 1985 Oct; 134(4):658-61. PubMed ID: 3897582
[TBL] [Abstract][Full Text] [Related]
17. Gouty diathesis and sarcoidosis in patient with recurrent calcium nephrolithiasis.
Harvey JA; Pak CY
J Urol; 1988 Jun; 139(6):1287-9. PubMed ID: 3373603
[TBL] [Abstract][Full Text] [Related]
18. Urine citrate and renal stone disease.
Goldberg H; Grass L; Vogl R; Rapoport A; Oreopoulos DG
CMAJ; 1989 Aug; 141(3):217-21. PubMed ID: 2665909
[TBL] [Abstract][Full Text] [Related]
19. The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation.
Berg C; Larsson L; Tiselius HG
J Urol; 1992 Sep; 148(3 Pt 2):979-85. PubMed ID: 1507355
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts.
Sakhaee K; Nicar M; Hill K; Pak CY
Kidney Int; 1983 Sep; 24(3):348-52. PubMed ID: 6645208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
